N-sulfoglucosamine sulfohydrolase recombinant Uses, Dosage, Side Effects and more
N-sulfoglucosamine sulfohydrolase recombinant is under investigation for the treatment of Mucopolysaccharidosis III and Sanfilippo Syndrome Type A (MPS IIIA).
| Trade Name | N-sulfoglucosamine sulfohydrolase recombinant |
| Generic | N-sulfoglucosamine sulfohydrolase recombinant |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
